AngioDynamics Dirección
Dirección controles de criterios 2/4
El CEO de AngioDynamics es Jim Clemmer , nombrado en Apr 2016, tiene una permanencia de 8.58 años. compensación anual total es $5.01M, compuesta por 15.6% salario y 84.4% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.17% de las acciones de la empresa, por valor de $3.20M. La antigüedad media del equipo directivo y de la junta directiva es de 6.4 años y 8.7 años, respectivamente.
Información clave
Jim Clemmer
Chief Executive Officer (CEO)
US$5.0m
Compensación total
| Porcentaje del salario del CEO | 15.6% |
| Permanencia del CEO | 8.6yrs |
| Participación del CEO | 1.2% |
| Permanencia media de la dirección | 6.4yrs |
| Promedio de permanencia en la Junta Directiva | 8.7yrs |
Actualizaciones recientes de la dirección
Recent updates
AngioDynamics, Inc. (NASDAQ:ANGO) Just Released Its Annual Results And Analysts Are Updating Their Estimates
Jul 19
Improved Revenues Required Before AngioDynamics, Inc. (NASDAQ:ANGO) Stock's 26% Jump Looks Justified
Jul 18AngioDynamics: A Story To Monitor
May 14A Leaner AngioDynamics Is A High-Risk Execution-Driven Story
Apr 09AngioDynamics, Inc.'s (NASDAQ:ANGO) Shares Bounce 26% But Its Business Still Trails The Industry
Apr 06AngioDynamics: Restructuring Initiative May Not Go Far Enough
Jan 14AngioDynamics (NASDAQ:ANGO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Oct 12AngioDynamics (NASDAQ:ANGO) Is Carrying A Fair Bit Of Debt
Mar 31AngioDynamics Non-GAAP EPS of -$0.06 misses by $0.04, revenue of $81.5M misses by $1.93M, reaffirms FY guidance
Oct 06AngioDynamics: Lack Of Upside Capture Remains, Continue To Hold
Sep 29Is AngioDynamics (NASDAQ:ANGO) Using Debt In A Risky Way?
Sep 02AngioDynamics Non-GAAP EPS of $0.01 in-line, revenue of $87M beats by $4.09M
Jul 12Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Aug 31 2024 | n/a | n/a | -US$243m |
| May 31 2024 | US$5m | US$783k | -US$184m |
| Feb 29 2024 | n/a | n/a | -US$192m |
| Nov 30 2023 | n/a | n/a | -US$14m |
| Aug 31 2023 | n/a | n/a | US$6m |
| May 31 2023 | US$4m | US$756k | -US$52m |
| Feb 28 2023 | n/a | n/a | -US$37m |
| Nov 30 2022 | n/a | n/a | -US$33m |
| Aug 31 2022 | n/a | n/a | -US$33m |
| May 31 2022 | US$6m | US$736k | -US$27m |
| Feb 28 2022 | n/a | n/a | -US$40m |
| Nov 30 2021 | n/a | n/a | -US$38m |
| Aug 31 2021 | n/a | n/a | -US$34m |
| May 31 2021 | US$4m | US$720k | -US$32m |
| Feb 28 2021 | n/a | n/a | -US$169m |
| Nov 30 2020 | n/a | n/a | -US$171m |
| Aug 31 2020 | n/a | n/a | -US$170m |
| May 31 2020 | US$3m | US$716k | -US$167m |
| Feb 29 2020 | n/a | n/a | -US$7m |
| Nov 30 2019 | n/a | n/a | -US$6m |
| Aug 31 2019 | n/a | n/a | -US$7m |
| May 31 2019 | US$3m | US$687k | -US$11m |
| Feb 28 2019 | n/a | n/a | -US$34m |
| Nov 30 2018 | n/a | n/a | -US$16m |
| Aug 31 2018 | n/a | n/a | -US$12m |
| May 31 2018 | US$3m | US$643k | -US$6m |
Compensación vs. Mercado: La compensación total de Jim($USD5.01M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD1.46M).
Compensación vs. Ingresos: La compensación de Jim ha aumentado mientras la empresa no es rentable.
CEO
Jim Clemmer (60 yo)
8.6yrs
Permanencia
US$5,005,971
Compensación
Mr. James C. Clemmer, also known as Jim, has been the Chief Executive Officer, President and a Director of AngioDynamics, Inc. since joining it on April 04, 2016. Mr. Clemmer served as Group President of t...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President & Director | 8.6yrs | US$5.01m | 1.17% $ 3.2m | |
| Executive VP & CFO | 5.1yrs | US$1.82m | 0.26% $ 715.1k | |
| Senior VP and GM of Global Vascular Access & Oncology Business Unit | 8.5yrs | US$1.01m | 0.18% $ 488.5k | |
| Senior Vice President of Regulatory Affairs | 7.6yrs | US$995.08k | 0.11% $ 308.3k | |
| Senior VP & GM of Endovascular Therapies and International | 3.4yrs | US$1.23m | 0.14% $ 376.3k | |
| Vice President of Communications | 4.8yrs | sin datos | sin datos | |
| Senior Vice President of Business Development & Strategy | 9.7yrs | sin datos | sin datos | |
| Senior Vice President of Human Resources | 5.2yrs | sin datos | sin datos | |
| Senior Vice President of Information Technology | 13.2yrs | sin datos | sin datos | |
| Senior Vice President of Scientific & Clinical Affairs | 3.8yrs | sin datos | sin datos |
6.4yrs
Permanencia media
56yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de ANGO es experimentado (6.4 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President & Director | 8.6yrs | US$5.01m | 1.17% $ 3.2m | |
| Independent Director | 8yrs | US$225.11k | 0.21% $ 587.1k | |
| Independent Director | 17.8yrs | US$234.81k | 0.30% $ 805.6k | |
| Independent Non-Executive Chairman | 20.7yrs | US$262.01k | 0.37% $ 1.0m | |
| Independent Director | 8.8yrs | US$229.13k | 0.21% $ 584.9k | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 5.3yrs | US$224.51k | 0.18% $ 488.9k |
8.7yrs
Permanencia media
63.5yo
Promedio de edad
Junta con experiencia: La junta directiva de ANGO se considera experimentada (8.7 años de antigüedad promedio).